Resistance to β-lactams of Acinetobacter baumannii: Evolution and emergence of new mechanisms;Résistance aux β-lactamines chez Acinetobacter baumannii: Évolution et émergence de nouveaux mécanismes

Antibiotiques

Volumn 8, Issue 2, 2006, Pages 100-107

  Poirel, L ^a   Nordmann, P ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

Acinetobacter baumannii; Antibiotic resistance; Carbapenemase; lactams

Indexed keywords

BACTERIAL ENZYME; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE AMPC; CARBAPENEM; CEPHALOSPORINASE; OXACILLINASE; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL INFECTION; BACTERIUM ISOLATE; DRUG MECHANISM; GENE SEQUENCE; HOSPITAL INFECTION; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION;

EID: 33646682136     PISSN: 12945501     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1294-5501(06)70805-6     Document Type: Article

References (70)

1. BERGOGNE-BÉRÉZIN E, TOWNER KJ. Acinetobacter spp. as nosocomial pathogens : microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996 ; 9 : 148-65.
2. BERGOGNE-BEREZIN E. The increasing role of Acinetobacter species as nosocomial pathogens. Curr Infect Dis Rep 2001 ; 3 : 440-4.
3. BERGOGNE-BÉRÉZIN E, JOLY-GUILLOU ML, TOWNER KJ. In Acinetobacter : microbiology, epidemiology, infections, management. CRC Press, Inc., Boca Raton, Florida 1996.
4. BERGOGNE-BEREZIN E. The increasing significance of outbreaks of Acinetobacter spp. : the need for control and new agents. J Hosp Infect 1995 ; 30 : 441-52.
5. VAN LOOVEREN M, GOOSSENS H, ARPAC Steering Group. Antimicrobial resistance of Acinetobacter spp. in Europe. Clin Microbiol Infect 2004 ; 10 : 684-704.
6. HANBERGER H, GARCIA-RODRIGUEZ JA, GOBERNADO M, et al. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups. JAMA 1999 ; 281 : 67-71.
7. TURNER PJ. Susceptibility of meropenem and comparators tested against 30,634 Enterobacteriaceae isolated in the MYSTIC Programme (1997-2003). Diagn Microbiol Infect Dis 2004 ; 50 : 291-3.
8. VAN DESSEL H, DIJKSHOORN L, van der REIJDEN T, et al. Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. Res Microbiol 2004 ; 155 : 105-12.
9. DIJKSHOORN L, AUCKEN H, GERNER-SMIDT P, et al. Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. J Clin Microbiol 1996 ; 34 : 1519-25.
10. BOU G, MARTINEZ-BELTRAN J. Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC β-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 2000 ; 44 : 428-32.
11. HÉRITIER C, POIREL L, FOURNIER PE, et al. Characterization of the naturally-occurring oxacillinase of Acinetobacter baumannii. Antimicrob Agents Chemother 2005 ; 49 : 4174-9.
12. HÉRITIER C, POIREL L, LAMBERT T, et al. Contribution of acquired carbapenem-hydrolyzing oxacillinases in carbapenem-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2005 ; 49 : 3198-202.
13. BROWN S, YOUNG HK, AMYES SGB. Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin Microbiol Infect 2005 ; 11 : 15-23.
14. SATO K, NAKAE T. Outer membrane permeability of Acinetobacter calcoaceticus and its implication in antibiotic resistance. J Antimicrob Chemother 1991 ; 28 : 35-45.
15. OBARA M, NAKAE T. Mechanisms of resistance to β-lactam antibiotics in Acinetobacter calcoaceticus. J Antimicrob Chemother 1991 ; 28 : 791-800.
16. GOLDSTEIN FW, LABIGNE-ROUSSEL A, GERBAUD G, et al. Transferable plasmid-mediated antibiotic resistance in Acinetobacter. Plasmid 1983 ; 10 : 138-47.
17. DEVAUD M, KAYSER FH, BACHI B. Transposon-mediated multiple antibiotic resistance in Acinetobacter strains. Antimicrob Agents Chemother 1982 ; 22 : 323-9.
18. PAUL G, JOLY-GUILLOU ML, BERGOGNE-BEREZIN E, et al. Novel carbenicillin-hydrolyzing β-lactamase (CARB-5) from Acinetobacter calcoaceticus var. anitratus. FEMS Microbiol Lett 1989 ; 50 : 45-50.
19. CORVEC S, CAROFF N, ESPAZE E, et al. AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains. J Antimicrob Chemother 2003 ; 52 : 629-35.
20. SEGAL H, NELSON EC, ELISHA BG. Genetic environment of ampC in Acinetobacter baumannii clinical isolate. Antimicrob Agents Chemother 2004 ; 48 : 612-4.
21. HÉRITIER C, POIREL L, NORDMANN P. Cephalosporinase overexpression as a result of insertion of ISAba1 in Acinetobacter baumannii. Clin Microbiol Infect 2006 ; 12 : 123-30.
22. HUANG ZM, MAO PH, CHEN Y, et al. Study on the molecular epidemiology of SHV type β-lactamase-encoding genes of multiple-drug-resistant Acinetobacter baumannii. Zhonghua Liu Xing Bing Xue Za Zhi 2004 ; 25 : 425-7.
23. BONNET R. Growing group of extended-spectrum β-lactamases : the CTX-M enzymes. Antimicrob Agents Chemother 2004 ; 48 : 1-14.
24. NAGANO N, NAGANO Y, CORDEVANT C, et al. Nosocomial transmission of CTX-M-2 β-lactamase-producing Acinetobacter baumannii in a neurosurgery ward. J Clin Microbiol 2004 ; 42 : 3978-84.
25. VAHABOGLU H, OZTURK R, AYGUN G, et al. Widespread detection of PER-1-type extended-spectrum β-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey : a nationwide multicenter study. Antimicrob Agents Chemother 1997 ; 41 : 2265-9.
26. PER-1 gene in gram-negative bacteria. Antimicrob Agents Chemother 2005 ; 49 : 1708-13.
27. POIREL L, KARIM A, MERCAT A, et al. Extended-spectrum β-lactamase-producing strain of Acinetobacter baumannii isolated from a patient in France. J Antimicrob Chemother 1999 ; 43 : 157-8.
28. JEONG SH, BAE IK, KWON SB, et al. Investigation of a nosocomial outbreak of Acinetobacter baumannii producing PER-1 extended-spectrum β-lactamase in an intensive care unit. J Hosp Infect 2005 ; 59 : 242-8.
29. POIREL L, MENUTEAU O, AGOLI N, et al. Outbreak of extended-spectrum β-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J Clin Microbiol 2003 ; 41 : 3542-7.
30. CARBONNE A, NAAS T, BLANCKAERT K, et al. Investigation of a nosocomial outbreak of extended-spectrum β-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a hospital setting. J Hosp Infect ; 60 : 14-8.
31. RICHET HM, MOHAMMED J, MCDONALD LC, et al. Building communication networks: international network for the study and prevention of emerging antimicrobial resistance. Emerg Infect Dis 2001 ; 7 : 319-22.
32. WALSH TR, TOLEMAN MA, POIREL L, et al. Metallo-β-lactamases: the quiet before the storm? Clin Microbiol Rev 2005 ; 18 : 306-25.
33. NAAS T, NORDMANN P. OXA-type β-lactamases. Curr Pharm Des 1999 ; 5 : 865-79.
34. POIREL L, NORDMANN P. Acquired carbapenem-hydrolyzing β-lactamases and their genetic support. An update. Med Chem Rev - Online 2005 ; 2 : 183-95.
35. DONALD HM, SCAIFE W, AMYES SG, et al. Sequence analysis of ARI-1, a novel OXA β-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92. Antimicrob Agents Chemother 2000 ; 44 : 196-9.
36. JEON BC, JEONG SH, BAE IK, et al. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 β-lactamase in Korea. J Clin Microbiol 2005 ; 43 : 2241-5.
37. HÉRITIER C, DUBOUIX A, POIREL L, et al. A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolyzing oxacillinase OXA-58. J Antimicrob Chemother 2005 ; 55 : 115-8.
38. DA SILVA GJ, QUINTEIRA S, BERTOLO E, et al. Long-term dissemination of an OXA-40 carbapenemase-producing Acinetobacter baumannii clone in the Iberian Peninsula. J Antimicrob Chemother 2004 ; 54 : 255-8.
39. LOPEZ-OTSOA F, GALLEGO L, TOWNER KJ, et al. Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain. J Clin Microbiol 2002 40 : 4741-3.
40. MARQUÉ S, POIREL L, HÉRITIER C, et al. Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe. J Clin Microbiol 2005 ; 43 : 4885-8.
41. FERNANDEZ-CUENCA F, MARTINEZ-MARTINEZ L, CONEJO MC, et al. Relationship between β-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. J Antimicrob Chemother 2003 ; 51 : 565-74.
42. BOU G, CERVERO G, DOMINGUEZ MA, et al. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of β-lactamases. J Clin Microbiol 2000 ; 38 : 3299-305.
43. LIMANSKY AS, MUSSI MA, VIALE AM. Loss of a 29-kilodalton outer membrane protein in Acinetobacter baumannii is associated with imipenem resistance. J Clin Microbiol 2002 ; 40 : 4776-8.
44. MUSSI MA, LIMANSKY AS, VIALE AM. Acquisition of resistance to carbapenems in multidrug-resistant clinical strains of Acinetobacter baumannii: natural insertional inactivation of a gene encoding a member of a novel family of β-barrel outer membrane proteins. Antimicrob Agents Chemother 2005 ; 49 : 1432-40.
45. MAGNET S, COURVALIN P, LAMBERT T. Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob Agents Chemother 2001 ; 4 : 3375-80.
46. MARCHAND I, DAMIER-PIOLLE L, COURVALIN P, et al. Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system. Antimicrob Agents Chemother 2004 ; 48 : 3298-304.
47. FETIYE K, KARADENIZLI A, OKAY E, et al. Comparison in a rat thigh abscess model of imipenem, meropenem and cefoperazone-sulbactam against Acinetobacter baumannii strains in terms of bactericidal efficacy and resistance selection. Ann Clin Microbiol Antimicrob 2004 ; 3 : 2.
48. JOLY-GUILLOU ML, DECRE D, HERRMAN JL, et al. Bactericidal in-vitro activity of β-lactams and β-lactamase inhibitors, alone or associated, against clinical strains of Acinetobacter baumannii: effect of combination with aminoglycosides. J Antimicrob Chemother 1995 ; 36 : 619-29.
49. MONTERO A, ARIZA J, CORBELLA X, et al. Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model. J Antimicrob Chemother 2004 ; 54 : 1085-91.
50. MICHALOPOULOS A, KASIAKOU S, ROSMARAKIS E, et al. Cure of multidrug-resistant Acinetobacter baumannii bacteraemia with continuous intravenous infusion of colistin. Scand J Infect Dis 2005 ; 37 : 142-5.
51. MICHALOPOULOS AS, TSIODRAS S, RELLOS K, et al. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect 2005 ; 11 : 115-21.
52. PACHON-IBANEZ ME, JIMENEZ-MEJIAS ME, PICHARDO C, et al. Activity of tigecycline (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenem. Antimicrob Agents Chemother 2004 ; 48 : 4479-81.
53. QUALE J, BRATU S, LANDMAN D, et al. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clin Infect Dis 2003 ; 37 : 214-20.
54. MANIKAL VM, LANDMAN D, SAURINA G, et al. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis 2000 ; 31 : 101-6.
55. CORNAGLIA G, RICCIO ML, MAZZARIOL A, et al. Appearance of IMP-1 metallo-β-lactamase in Europe. Lancet 1999 ; 353 : 899-900.
56. IMP allelic variants carried by gene cassettes of different phylogeny. Antimicrob Agents Chemother 2000 ; 44 : 1229-35.
57. CHU YW, AFZAL-SHAH M, HOUANG ET, et al. IMP-4, a novel metallo-β-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob Agents Chemother 2001 ; 45 : 710-4.
58. IMP-5, a new integron-borne metallo-β-lactamase gene from an Acinetobacter baumannii nosocomial isolate in Portugal. FEMS Microbiol Lett 2002 ; 215 : 33-9.
59. VIM-2 gene cassettes. J Antimicrob Chemother 2002 ; 49 : 837-40.
60. JONES RN, DESHPANDE L, FRITSCHE TR, et al. Determination of epidemic clonality among multidrug-resistant strains of Acinetobacter spp. and Pseudomonas aeruginosa in the MYSTIC Programme (USA, 1999-2003). Diagn Microbiol Infect Dis 2004 ; 49 : 211-6.
61. PLOY MC, DENIS F, COURVALIN P, et al. Molecular characterization of integrons in Acinetobacter baumannii: description of a hybrid class 2 integron. Antimicrob Agents Chemother 2000 ; 44 : 2684-8.
62. VILA J, NAVIA M, RUIZ J, et al. Cloning and nucleotide sequence analysis of a gene encoding an OXA-derived β-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 1997 ; 41 : 2757-9.
63. BOU G, OLIVER A, MARTINEZ-BELTRAN J. OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob Agents Chemother 2000 ; 44 : 1556-61.
64. AFZAL-SHAH M, WOODFORD N, LIVERMORE DM. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 2001 ; 45 : 583-8.
65. NAVIA MM, RUIZ J, VILA J. Characterization of an integron carrying a new class D β-lactamase (OXA-37) in Acinetobacter baumannii. Microb Drug Resist 2002 ; 8 : 261-5.
66. HÉRITIER C, POIREL L, AUBERT D, et al. Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii. Antimicrob Agents Chemother 2003 ; 47 : 268-73.
67. POIREL L, MARQUÉ S, HÉRITIER C, et al. OXA-58, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother 2005 ; 49 : 202-8.
68. GALES AC, TOGNIM MC, REIS AO, et al. Emergence of an IMP-like metallo-enzyme in an Acinetobacter baumannii clinical strain from a Brazilian teaching hospital. Diagn Microbiol Infect Dis 2003 ; 45 : 77-9.
69. LEE K, LEE WG, UH Y, et al. VIM- and IMP-type metallo-β-lactamase- producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals. Emerg Infect Dis 2003 ; 9 : 868-71.
70. SHIBATA N, DOI Y, YAMANE K, et al. PCR typing of genetic determinants for metallo-β-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron. J Clin Microbiol 2003 ; 41 : 5407-13.